CARLSBAD, Calif.--(BUSINESS WIRE)--Applied Biosystems, a division of Life Technologies Corporation (NASDAQ:LIFE), today announced the launch of the life science industry’s first integrated real-time PCR solution for measuring residual DNA impurities from Chinese Hamster Ovary (CHO) host cells. The new solution significantly enhances the ability of biopharmaceutical companies to rapidly and accurately quantitate the impurities. The CHO cell lines are the primary medium used by biopharmaceutical companies to develop biological drugs, which are designed to treat a variety of medical conditions, including cancer, cardiovascular disease, inflammatory diseases, multiple sclerosis and viral infection.
